Can Biologics Improve My Rotator Cuff Repair Results?

Yes, biologics such as platelet-rich plasma (PRP), mesenchymal stem cells, and tissue grafts may improve outcomes after rotator cuff repair. These treatments support rotator cuff healing, strengthen tendon-to-bone integration, and reduce the risk of retear, especially in patients with larger rotator cuff tears.

At Total Orthopedics and Sports Medicine, Dr. Charles Ruotolo, a Golden Lion Award recipient, carefully evaluates tear size, tendon quality, activity level, patient age, and overall health before recommending treatment. He uses platelet-rich plasma to deliver concentrated growth factors that support the body’s natural healing processes. If tissue quality is poor or the tear is complex, he may use graft-supported surgical repair to strengthen the repair site. Contact us at 855-321-6784 to schedule your consultation.

How Can Biologics Improve Rotator Cuff Repair?

A biologic approach can improve rotator cuff repair by supporting tendon-to-bone healing, reducing inflammation, and strengthening the repair site. For instance, treatments such as platelet-rich plasma, bone marrow aspirate concentrate, and cell-based therapies deliver growth factors that may reduce the risk of retear.

Moreover, during surgery, the repaired tendon must gradually reconnect with the bone while forming durable tissue around the sutures. However, limited blood supply, poor tendon quality, aging, diabetes, smoking, and massive rotator cuff tears can interfere with this process. In such cases, biologic agents create a favorable healing environment by stimulating cellular activity, collagen production, blood vessel formation, and tissue remodeling. Therefore, most surgeons use biologics to achieve precise surgical fixation, facilitate rehabilitation, and manage risk factors.

What Biologics Are Used in Rotator Cuff Surgery?

Platelet-rich plasma (PRP), platelet-rich fibrin, bone marrow aspirate concentrate (BMAC), mesenchymal stem cells, and bioinductive collagen implants are used in rotator cuff surgery. Acellular dermal grafts, amniotic tissue products, and growth-factor-based treatments are also used in the surgical interventions to accelerate healing process.

Here’s how these biologic therapies are used to improve healing and patient outcomes:

Platelet-Rich Plasma (PRP)

Platelet-rich plasma is prepared by concentrating platelets from the patient’s blood. During arthroscopic rotator cuff repair, the surgeon injects PRP for shoulder pain around the repaired tendon and tendon-to-bone attachment site. The platelet-derived growth factors support cellular activity, collagen production, blood vessel formation, and tissue repair. It also reduces structural retear rates in selected repairs with larger tears.

Platelet-Rich Fibrin

Platelet-rich fibrin is another blood-derived biologic, but it forms a thicker fibrin matrix that can remain at the repair site longer than liquid PRP. This matrix serves as a temporary scaffold, gradually releasing platelets and growth factors around the repaired tendon. Surgeons may place it between the tendon and bone or over the completed repair.

Bone Marrow Aspirate Concentrate (BMAC)

BMAC is prepared by collecting bone marrow, commonly from the patient’s pelvis, and concentrating its cellular components. It contains platelets, signaling proteins, progenitor cells, and a small population of mesenchymal stromal cells. During rotator cuff repair, BMAC may be injected directly into the tendon-bone interface to support biological healing. Moreover, it may improve tendon integrity and reduce the risk of revision or retear. According to an early clinical study published in NCBI, concentrated bone marrow aspirate improved tendon structural integrity on postoperative imaging and reduced the need for treatment of rotator cuff failure.

Mesenchymal Stem Cells

Mesenchymal stem cells can be obtained from bone marrow, adipose-derived stem cells, or other connective tissues. In rotator cuff surgery, they may be injected into the area around the repaired tendon. This stem cell therapy supports rotator cuff tendon healing by releasing biological signals that regulate inflammation and recruit reparative cells. It also stimulates the formation of collagen and extracellular matrix components.

Bioinductive Collagen Implants

A bioinductive collagen implant is a thin, resorbable scaffold placed over the surface of the damaged or repaired rotator cuff tendon. Rather than replacing the tendon, it encourages the patient’s cells and blood vessels to grow into the implant, potentially increasing tendon thickness and improving tissue quality. These implants may be used for certain partial-thickness tears or to repair full-thickness tears with weak tendon tissue. In fact, the PMC study reported that bioinductive collagen implant significantly reduced the one-year retear rate.

Acellular Dermal Grafts

Acellular dermal grafts are human or animal dermal tissues processed to remove living cells while preserving the collagen framework. The graft is secured over or between damaged tendon tissue to provide mechanical reinforcement and a scaffold for cellular ingrowth. Surgeons commonly consider these grafts for large or massive tears, revision procedures, poor-quality tendons, and some irreparable tears.

A NIH clinical study also evaluated acellular human dermal matrix augmentation in large, two-tendon tears measuring more than 3 cm. The augmented group had better repair integrity and improved clinical scores.

Amniotic Tissue Products

Amniotic tissue products are derived from donated placental tissues and may contain extracellular matrix proteins, cytokines, and other biological signaling molecules. During rotator cuff repair, they may be injected around the tendon-bone interface to create a supportive healing environment and regulate excessive inflammation or scar formation.

Growth-Factor-Based Treatments

Growth-factor-based treatments deliver biological signals intended to stimulate tendon cells, collagen production, blood components, and bone-tendon integration. These biologic treatments may involve:

1. Vascular endothelial growth factor
2. Transforming growth factor β (TGFβ)
3. Basic fibroblast growth factor
4. Osteoinductive growth factors
5. Bone morphogenetic proteins and other signaling molecules

Which Factors Affect Biologics Performance?

Biologics performance in rotator cuff surgery depends on the product’s preparation, cell or platelet concentration, leukocyte content, dose, delivery site, and timing. Other factors, such as tear size, tendon quality, patient age, smoking, diabetes, surgical technique, and rehabilitation adherence, also affect the treatment’s effectiveness in supporting tendon-to-bone healing.

In addition, differences in centrifugation, platelet concentration, cell viability, growth factor levels, activation methods, and leukocyte content can result in varying healing rates. Here’s how these factors can affect tissue regeneration and biologics performance:

Product Preparation

The preparation method determines the final biologic composition and its healing potential. Differences in blood or bone marrow collection, anticoagulants, processing time, filtration, storage, and handling can alter platelet recovery, cell quality, leukocyte levels, and protein content. Therefore, consistent preparation protocols are essential for producing predictable clinical results.

Centrifugation Method

Centrifugation speed, duration, temperature, and the number of spinning cycles directly affect the concentration of components in the final product. Although aggressive processing may increase cellular concentration, it can also activate or damage platelets, reducing cell viability. As a result, single-spin and double-spin systems may produce biologics with substantially different regenerative and inflammatory properties.

Platelet Concentration

Platelets release signaling proteins that support cell recruitment, collagen formation, blood-vessel development, and tissue remodeling. However, a higher concentration does not lead to better healing. Moreover, excessively concentrated products can create an imbalanced biological environment, while insufficient concentrations may provide limited stimulation.

Cell Concentration

The cellular content is particularly important in bone marrow aspirate concentrate and mesenchymal stromal cell therapies. Products containing greater numbers of viable nucleated and progenitor cells may provide stronger regenerative signaling. However, cell counts vary across collection sites, aspiration methods, patient characteristics, and concentration systems, making direct comparisons between treatments difficult.

Cell Viability

Only functional cells can respond to the injured environment and release factors that support repair. Delayed processing, excessive centrifugation, unsuitable storage conditions, temperature changes, and poor handling can reduce viability. Therefore, biologics should be prepared and delivered under controlled conditions that preserve cellular function from collection until application at the repair site.

Leukocyte Content

Leukocytes impact inflammation and tissue remodeling after rotator cuff repair. Leukocyte-rich products may provide antimicrobial and immune-regulating effects, but they can also increase inflammatory cytokine and enzyme activity.

Growth-Factor Levels

PRP and other biologics contain growth factors such as platelet-derived growth factor, transforming growth factor beta, vascular endothelial growth factor, and insulin-like growth factor. These proteins regulate cell migration, collagen synthesis, angiogenesis, and extracellular matrix formation. However, their concentrations vary among patients and across preparation systems, leading to different healing responses.

Activation Method

PRP may be activated naturally through contact with collagen or artificially with substances such as calcium chloride or thrombin. Activation may impact clot formation and the speed at which growth factors are released. Moreover, rapid activation can create an immediate biological response, whereas gradual activation may provide a more sustained release.

Biologic Dose

The treatment dose includes the volume applied and the total number of platelets or viable cells delivered. A small volume may not cover the entire repair site, while an excessive volume could disperse beyond the intended area. For example, a PMC systematic review trial found that 5 mL of leukocyte-poor PRP applied during surgery reduced retears in tears smaller than 3 cm.

Delivery Site

Biologics must reach the area where healing support is most needed. Applying the product directly at the tendon-to-bone interface may improve local exposure to platelets, cells, and signaling molecules. In contrast, material placed away from the repair site or washed out by arthroscopic fluid may provide less benefit. Moreover, secure delivery through injection, clot formation, fibrin matrices, or scaffolds can improve local retention.

Treatment Timing

Surgeons usually inject biologics during shoulder surgery, immediately after arthroscopic repair, or through a series of postoperative injections. Intraoperative application provides immediate exposure during the early inflammatory stage, while later injections may support subsequent proliferative and remodeling phases.

Tear Size

Larger and more retracted tears have fewer healthy tendon fibers, greater mechanical stress, and a larger area requiring biological integration. As a result, these tears generally carry a higher risk of incomplete healing or retear. In such cases, biologic strategies may support tissue healing. But they cannot fully compensate for severe tissue loss, advanced retraction, or excessive tension across the repair.

Tendon and Muscle Quality

Degeneration, fatty infiltration, muscle atrophy, reduced vascularity, and poor tendon thickness can limit the response to biologic treatment. A product may deliver useful growth factors or regenerative cells, yet successful healing still requires tissue capable of responding to those signals. Poor-quality tissue also makes secure fixation more difficult and increases the chances of structural failure.

Who May Benefit From Biologic Augmentation?

Biologic augmentation may benefit patients with large or revision tears, poor tissue quality, tendon retraction, and fatty infiltration. Patients with advanced age, diabetes, smoking history, obesity, or osteoporosis also have potential benefits in pain reduction.

Here’s how these conditions can improve patient outcomes:

Revision Rotator Cuff Tears

Surgeons perform revision surgery when a previously repaired tendon fails or tears again. These cases often involve scar tissue, weakened tendons, reduced blood supply, and limited tissue available for fixation. In such cases, biological grafts, collagen implants, or platelet-based products may provide additional support, although outcomes still depend on tear size, muscle condition, and repairability.

Poor Tendon Tissue Quality

Degenerated, thin, or frayed tendon tissue may not hold sutures securely during rotator cuff repair. Therefore, biological regenerative treatments can strengthen the repair area and provide a scaffold for new tissue formation.

Tendon Retraction

A retracted tendon has pulled away from its normal attachment on the upper arm bone. Greater retraction makes the tendon harder to mobilize and increases tension after repair, potentially compromising healing. In this case, augmentation may help protect the repair and improve structural support. But severe retraction can still limit the chance of a complete anatomical repair.

Fatty Infiltration

A chronic rotator cuff tear gradually replaces healthy muscle tissue with fat, causing fatty infiltration. This change reduces muscle strength and can impair tendon healing after surgery. Patients with moderate fatty degeneration may benefit more from augmentation, as this condition increases their risk of repair failure.

Advanced Age

Older patients commonly have reduced tendon vascularity, lower cellular activity, weaker bone, and more degenerative tissue. These factors can slow tendon-to-bone healing and increase the possibility of retearing. Biologic augmentation in such cases may support the shoulder joint healing in carefully selected older adults.

Diabetes

Diabetes can impair blood circulation, collagen production, inflammatory regulation, and tissue remodeling. As a result, patients with poorly controlled blood glucose may experience slower healing rates and a greater risk of structural failure. In this case, biologic augmentation may provide additional healing support and reduce other medical risks.

Smoking History

Nicotine and other tobacco-related chemicals can restrict blood flow and interfere with oxygen delivery to healing tendon tissue. Current and long-term smokers may therefore have weaker biological conditions for repair. Although augmentation may be considered in high-risk cases, stopping smoking before and after surgery is essential because biologic products cannot fully overcome continued tobacco exposure.

Osteoporosis

Osteoporosis reduces bone mineral density at the site where the repaired tendon is anchored. Weaker bone may limit fixation strength and disrupt tendon-to-bone integration. In this situation, biological augmentation improves the surrounding healing environment. But patients may also require an assessment for osteoporosis and minimally invasive treatment to reduce fixation problems.

How Do Doctors Use Biologics During Surgery?

During surgery, Dr. Charles Ruotolo, our shoulder specialist, applies biologics, such as bone grafts or stem cell concentrates, directly to the surgical site to support tissue regeneration. He also carefully manages systemic biologic medications before and after surgery to help control autoimmune conditions.

Moreover, in orthopedic surgeries, Dr. Charles Ruotolo uses biologics, such as Bone Morphogenetic Proteins (BMPs) or Platelet-Rich Plasma (PRP), directly at the surgical site. These proteins stimulate the body’s natural ability to form new bone, repair tendons, and heal rotator cuff injuries. On the other hand, he uses biologic matrix materials as scaffolds or skin substitutes during reconstructive procedures to close complex wounds and promote healthy tissue growth. Schedule a consultation to get effective biologic treatment for your surgical recovery.

Do Biologics Impact Recovery or Rehabilitation?

Yes, biologics can affect recovery after surgery by supporting tissue healing, reducing the risk of structural failure, and sometimes improving pain or function. However, they do not replace rehabilitation or automatically shorten recovery. Therefore, patients must follow surgeon-directed timelines for protection, mobility, strengthening, and return to activity.

Moreover, during the early phase of recovery, patients should protect the repair while completing approved passive-motion exercises. Although growth factors in biologics may reduce early-stage post-operative discomfort, successful rehabilitation still depends on the following factors:

1. Surgical protection
2. Regular targeted exercises
3. Gradual loading
4. Compliance with the surgeon’s instructions

What Are the Risks of Rotator Cuff Biologics?

Rotator cuff biologics may cause temporary pain, swelling, inflammation, bleeding, infection, or tissue reactions. Bone marrow harvesting can also cause donor-site discomfort, while donor-derived grafts may trigger immune responses or transmit disease.

However, the outcomes may vary because product preparation, dosage, evidence quality, and regulatory status differ. Besides that, the specific risk may also depend on the treatment used. For instance, clinicians prepare PRP from the patient’s blood while collecting bone marrow aspirate concentrate via an additional harvesting procedure. In this case, biologic patches introduce implanted material that may integrate poorly or provoke a sterile inflammatory response.

Another concern is the uncertain effectiveness. Platelet concentration, leukocyte content, processing methods, application timing, patient age, tear size, and tissue quality can impact results. As a result, a biologic treatment that improves tendon healing in one patient may offer limited clinical benefit in another.

Does Health Insurance Cover Biologic Treatment?

Yes, health insurers may cover biologic treatment when the FDA has approved it, a doctor considers it medically necessary, and the policy covers the diagnosis. However, insurers often exclude experimental orthobiologic procedures, including PRP or stem-cell injections for rotator cuff injuries, or require prior authorization.

In addition, coverage depends on the biologic product, the purpose of treatment, the insurance provider, and the policy terms. For example, insurers may process biologic drugs administered by physicians under the medical benefit, while they process self-administered prescriptions through the pharmacy benefit. Formularies may also impose step therapy, specialist prescribing, or prior-authorization requirements. Similarly, several Medicare coverage policies exclude PRP for joint and musculoskeletal conditions outside narrowly defined covered uses. Therefore, patients may need to pay the full cost of these experimental therapies.

What Should You Ask Before Choosing Biologics For Rotator Cuff?

Before choosing biologics for a rotator cuff tear, ask your doctor which product they plan to use, why they recommend it for your tear, and whether the FDA has approved it for that purpose. You should also ask about its risks, expected benefits, cost-effectiveness, insurance coverage, and whether it changes the surgery or recovery plan.

Moreover, ask whether your surgeon recommends platelet-rich plasma, bone marrow aspirate concentrate, a collagen implant, an acellular dermal graft, or another product. The surgeon should explain how the treatment relates to your tear size, tendon retraction, tissue quality, muscle atrophy, fatty infiltration, age, medical conditions, or previous failed repair. These factors can weaken the healing process, while surgeons may consider patch augmentation more often for massive or revision tears. Other than that, you must ask about infection, inflammation, immune reactions, graft failure, stiffness, donor-site discomfort, and the possibility that the treatment will provide no additional benefit.

You should also request a complete estimate covering the biologic product, harvesting, processing, surgical application, imaging, and follow-up care. This is because insurance providers often do not cover many orthobiologic therapies, even when doctors use them to support rotator cuff repair. At Total Orthopedics and Sports Medicine, we make high-quality orthopedic care more accessible by providing clear information about treatment costs. We accept a wide range of insurance plans and offer clear self-pay pricing with flexible payment options for patients without coverage. Our team carefully explains insurance benefits, referrals, co-pays, and other requirements while managing the necessary paperwork.

Get Advanced Rotator Cuff Treatment From Dr. Charles Ruotolo In Long Island

Living with an untreated or poorly managed rotator cuff tear can make everyday tasks difficult. If your surgeon does not properly evaluate biologic treatment as part of your repair, your tendon may heal more slowly, the tissue may remain weak, and you may continue to experience persistent pain.

At Total Orthopedics and Sports Medicine, Dr. Charles Ruotolo provides advanced rotator cuff care through precise diagnosis, minimally invasive repair techniques, and biologic augmentation. Our team also provides seamless coordination across diagnostics, imaging, pain management, and surgery under one roof. Additionally, we reassess care plans, allowing for real-time treatment adjustments. Visit at 115 Eileen Way, Syosset, NY 11791, or call us at 855-321-6784 to get advanced orthopedic care.

FAQs